Sola, Augusto – M.D.

Augusto Sola, M.D. is a CHOC Children’s Specialists Neonatologist, board certified in Pediatrics and Neonatology. Dr. Sola has been has over 20 years of experience in Neonatology in two different countries and in six different large centers. Currently, he is President of SIBEN and on sabbatical on International Neonatal Education and Health Care and has written two new books on neonatology.

 

Dr. Sola has extensive experience in Neonatal medicine and in Perinatal medicine. He trained under and worked with the pioneers of fetal physiology at the University of California, San Francisco and also worked for many years as the neonatologist of the Fetal Treatment Center at UCSF, one of the first such centers in the world dedicated to the treatment of human fetus with serious clinical conditions.

 

Dr. Sola received his medical degree at the University of Buenos Aires Medical School, Argentina. He completed his pediatric residency training and served his fellowship at the University of Massachusetts in Worcester, where he was later named Senior Chief Resident in Pediatrics.

 

Dr. Sola completed post graduate studies at the University of California in San Francisco and the Cardio Vascular Research Institute. Before returning to his home country, he worked for two years as a neonatologist in New Orleans (So. Baptist and Tulane).

 

Once in Argentina, he soon became Chief of Newborn Services at the “Hospital de Clínicas” of the University of Buenos Aires. There, Dr. Sola developed clinical neonatal intensive services and established mechanical ventilation; initiated training in neonatal medicine and, initiated the first neonatal fellowship program for MD’s with a completed pediatric residency.

 

At the National Pediatric Hospital (J.P. Garrahan Hospital), Dr. Sola was appointed Director of Neonatology and designed the neonatal unit and supporting services. During the process he developed the concept of “Neonatal Recovery Unit”, where the parents of infants who no longer needed intensive care, but remained ill and had to remain hospitalized, would live with their infants, improving the transition from hospital to home and shortening hospital stay. This was an original and revolutionary concept at the time. Dr. Sola developed the first organized programs in the nation for long-term follow-up of NICU graduates both at both the Hospital de Clínicas and at Garrahan Hospital.

 

Dr. Sola served as full Professor of Pediatrics at the University of Buenos Aires. He created the “Fundación para el Recien Nacido” a non profit organization that assisted poor families and ill newborns.

 

Dr. Sola returned to the United States to become Director of Neonatal Clinical Services at the University of California in San Francisco. There he joined distinguished specialists in the field, was part of the Fetal Treatment Center and was interim director of the ECMO program. He also became progressively more involved in research in areas of neonatal neurology. Dr. Sola then accepted the position of Professor of Pediatrics.

 

Dr. Sola moved on as Division Director of Neonatology at Cedars Sinai Medical Center and Professor of Pediatrics at UCLA. There he re-established the neonatal fellowship program, was given an endowed Chair and started to become involved in the study of neonatal oxygenation and outcome improvement.

 

Dr Sola was tenured Professor of Pediatrics, and Obstetrics and Gynecology, at Emory University in Atlanta where he also held the Goddard Scholarship and directed the Division of Neonatal Perinatal Medicine, the neonatal laboratory for investigations of the mechanisms of injury and protection to the developing brain and the neonatal fellowship training program. During his tenure at Emory and under his leadership, the division became more academically involved, the fellowship program grew exponentially, clinical and grant funding expanded notably and, most importantly, neonatal clinical outcomes improved.

 

Dr. Sola’s neonatal professional activities have encompassed education, research, administration and clinical care. He is an “appassionato clinician” and still takes calls in-house at night and on weekends. He has developed and collaborated to develop innumerable neonatal centers, in Latin America and in the United States.

 

Dr. Sola has developed and established training programs; he has helped many physicians and nurses in their education, training and careers. He stimulates and collaborates with many throughout the America’s and Spain. Some of his colleagues and friends have called him “a trigger” that makes things happen. One of his former trainees, Dr. Adrian Soto, who subsequently became an excellent friend and unfortunately died at a young age because of cancer, was the first one to call Dr. Sola “an enzyme”, he who acts on a substrate and makes the final product much better. Clinical work and improved infants’ outcomes have been his passion and a driving stimulus.

 

Achievements & Honors

 

Dr. Sola has been recognized with numerous prestigious awards including being recognized for his contributions to education and leadership as one of The Ten Distinguished Young Professionals in Argentina and nominated among The Ten Top in the world.

 

Dr. Sola also been a recipient of the following awards:

 

• American Academy of Pediatrics Christopherson Award, for his contributions to International Child Health
• University of California San Francisco, Faculty Teaching Award, Department of Pediatrics
• University of Massachusetts, First Recipient of the Braden E. Griffin M.D. Lectureship
• World Health Organization (WHO) Perinatal Collaborating Center, Atlanta, Georgia. Dr. Cicely Williams Award in Recognition of Excellence

 

Dr. Sola has been a visiting professor at many universities and medical centers in the USA and Latin America and has been named member of honor of neonatal societies and pediatric societies in Spain, Cuba, Colombia, Paraguay and others. In addition, Dr. Sola has been recognized as one of America’s Top Doctors, and among the Best Doctors in the Bay Area and in Atlanta. Furthermore, he was accepted as member of the American College of Ethical Physicians and is listed in WHO IS WHO in America for his professional accomplishments.

 

More Honors

 

• Who’s Who in America, 2008
• J. Braverman Award, Argentina Pediatric Society
• Ten Outstanding Young Professionals of Argentina International Junior Chamber, Argentina
• Award for Educational, Scientific and Clinical Contributions to Pediatrics in Paraguay
• “Top Doctors of America in Neonatal-Perinatal Medicine” Award
• Leadership Award, presented by the Center for Black Women’s Wellness, Inc.
• “Top Doctors of Atlanta” Award, WHO Perinatal collaborating Center: Dr. Cicely Williams Award in Recognition of Excellence.
• “American’s Top Doctors” — Castle Connolly Award
• Named Honorary or Distinguished Member of various International Pediatric Societies and Distinguished and Visiting Professorships, including Colombia, Cuba, Barcelona and Cataluña, Paraguay, Uruguay and the United States.

 

Societies

 

Dr. Sola is a member of the following societies:

 

• American Pediatric Society (APS)
• Society for Pediatric Research (SPR)
• American Academy of Pediatrics (AAP – Fellow)
• AAP Section on Community and International Child Health
• AAP Section on Perinatal Pediatrics
• Society for Neuroscience
• Southern Society for Pediatric Research (SSPR)
• New York Academy of Sciences
• American Association For The Advancement Of Science
• Eastern Society For Pediatric Research
• European Society for Pediatric Research
• SIBEN, Ibero American Society of Neonatology – SIBEN.net

 

Dr. Sola is a past member of these societies:

 

• Western Society for Pediatric Research (WSPR)
• American Thoracic Society (ATS)
• Pediatric Society of Argentina
• Latin American Society for Pediatric Research
• California Association of Neonatologists (CAN)
• National Association of Hispanic Physicians
• Southeastern Association of Neonatologists (SAN)
• Society for Critical Care Medicine (SCCM)

 

Educational Activities

 

Dr. Sola enjoys participating in education, and this occupies a significant portion of his life outside of work. His passion for Education started when he was a medical student. Dr. Sola has embraced the motto that “to teach is to learn twice” and has committed a significant proportion of his professional career to education. Over the years, he has received several prestigious teaching awards.

Publications

 

Dr. Sola has written two text books in Spanish in the field of Neonatal Medicine.

 

The first one, titled “Cuidados Intensivos Neonatales, Fisiopatologia and Terapeutica”. This book was extremely important in the developing field of newborn care, mostly in Latin American countries, in an era of no internet, e-mails or faxes.

 

The second one is a two volume book, written with his wife, Marta R. Rogido MD. It is entitled “Cuidados Especiales del Feto y el Recien Nacido” (Special Care of the Fetus and Newborn)

 

Dr Sola has written two neonatal books in the Spanish language: One is a comprehensive, multi author text book, with more than 60 authors from various countries and more than 1,500 pages, (“CUIDADOS NEONATALES: DESCUBRIENDO LA VIDA DE UN RECIÉN NACIDO ENFERMO” – ‘Neonatal Care: Discovering the life of a sick newborn’).

 

Dr. Sola also has many chapters in neonatal and pediatric manuals and textbooks written in the USA, Argentina, Chile, Mexico and other nations. In the field of Neonatal Medicine, Dr. Sola has over 80 publications in peer reviewed journals, both in basic research and in clinical topics.

 

Dr. Sola’s most important recent publications have focused in three topics:

 

1. Severe hypoxemic respiratory failure in the newborn, exploring the use of oral sildenafil (Viagra).
2. Mechanisms of injury and protection in the developing brain.
3. Improving outcomes by changing the practice of oxygen administration and pulse oximetry monitoring.

 

The recent most important publications in peer reviewed journals in those three areas of neonatal medicine include:

 

Recent Publications

 

1. Sola, A. Turn off the lights and the oxygen, when not needed: phototherapy and oxidative stress in the neonate. JPediatr (Rio J). 2007;83(4):293-296
2. Bouzas L, Bauer G, Novali L, Dilger A, Galina L, Falbo J, Díaz González L, Manzitti J, Sola A. Retinopathy of prematurity in the XXI century in a developing country: an emergency that should be resolved. An Pediatr (Barc). 2007 Jun;66(6):551-8
3. Sola A, Dieppa FD, Rogido MR. An evident view of evidence-based practice in perinatal medicine: absence of evidence is not evidence of absence. J Pediatr (Rio J). 2007 Sep-Oct;83(5):395-414
4. Sola A, Peng H, Rogido M, Wen TC. Animal models of neonatal stroke and response to erythropoietin and cardiotrophin-1. Int J Dev Neurosci. 2008 Feb;26(1):27-35.
5. Sola A, Rogido M. Iron, oxidant injury, and practice choices in preterm infants. J Pediatr. 2008 Feb;152(2):295-6;
6. Castillo A, Sola A, Baquero H, Neira F, Alvis R, Deulofeut R, Critz A. Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: is 85% to 93% an acceptable range? Pediatrics. 2008 May;121(5):882-9
7. Sola A. Oxygen for the preterm newborn: one infant at a time. Pediatrics. 2008 Jun;121(6):1257
8. Sola A. Oxygen in neonatal anesthesia: friend or foe? Curr Opin Anaesthesiol. 2008 Jun;21(3):332-9.
9. Sola A, Saldeño YP, Favareto V. Clinical practices in neonatal oxygenation: where have we failed? What can we do? J Perinatol. 2008 May;28 Suppl 1:S28-34.
10. Various and Sola A. (“Grupo de Trabajo Colaborativo Multicéntrico para la Prevención de la Ceguera en la Infancia por Retinopatía del Prematuro”) Recommendations for Retinopathy of Prematurity screening in at-risk populations Arch Argent Pediatr. 2008 Feb;106(1):71-6
11. Sola A, Golombek SG, Baquero H, Borbonet D, Cabañas F, Fajardo C, Goldsmit G, Lemus L, Miura E, Pellicer A, Pérez JM, Rogido M, Zambosco G, van Overmeire B: First SIBEN clinical consensus: diagnostic and therapeutic approach to patent ductus arteriosus in premature newborns. An Pediatr (Barc). 2008 Nov;69(5):454-81.
12. Bui T, Sequeira J, Wen TC, Sola A, Higashi Y, Kondoh H, Genetta T : ZEB1 links p63 and p73 in a novel neuronal survival pathway rapidly induced in response to cortical ischemia. PLoS ONE. 2009;4(2):e4373. Epub 2009 Feb 4.

 

Editorials / Commentary

 

1. Postnatal Steroids: Short-term gain, long-term pain? Neil N. Finer, MD, Alissa Craft, DO, MBA, Yvonne E. Vaucher, MD, MPH, Reese H. Clark, MD and Augusto Sola MD J Pediatr 2000:137:9-13
2. An evident view of evidence-based practice in perinatal medicine: absence of evidence is not evidence of absence. Augusto Sola, Fernando Dominguez Dieppa, Marta R. Rogido J Pediatr (Rio J). 2007;83(5): 395-414. (Evidence-based medicine, number needed to treat, randomized trials, outcome variables, treatment effects, critical reading, statistical significance.)
3. Sola, A. Turn off the lights and the oxygen, when not needed: phototherapy and oxidative stress in the neonate. J Pediatr (Rio J). 2007 Jul-Aug;83(4):293-6.

 

Mechanisms of injury and protection in the developing brain:

 

1. Sola A, Piecuch R. Prevalence of cerebral palsy: estimations, calculations and neonatal care. Pediatrics. 1994 Jan;93(1):152-3.
2. Sola A Berrios M, Gregory A, Ferriero D. Fructose-1,6-bisphosphate after hypoxic ischemic injury is protective to the neonatal rat brain. Brain Res. 1996 25;741(1-2):294-9
3. Westmark KD, Barkovich AJ, Sola A, Ferriero D, Partridge JC. Patterns and implications of MR contrast enhancement in perinatal asphyxia: a preliminary report. AJNR Am J Neuroradiol. 1995;16(4):685-92.
4. Barkovich AJ, Westmark K, Partridge C, Sola A, Ferriero DM. Perinatal asphyxia: MR findings in the first 10 days. AJNR Am J Neuroradiol. 1995;16(3):427-38.
5. Barkovich AJ. MR contrast enhancement of the normal neonatal brain. AJNR Am J Neuroradiol. 1997;18(9):1713-7
6. Van Bel F, Sola A, Roman C, Rudolph AM. Role of nitric oxide in the regulation of the cerebral circulation in the lamb fetus during normoxemia and hypoxemia. Biol Neonate. 1995;68(3):200-10
7. Van Bel, Sola A, Rudolph AR. Perinatal regulation of the cerebral circulation: role of nitric oxide and prostaglandins. Pediatr Res. 1997;42(3):299-304
8. Barkovich AJ. Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol. 1998;19(1):143-9
9. Finer N, Craft A, Vaucher Y, Clark R, Sola A. Postnatal Steroids: Short Term Gain, Long Term Pain? J Pediatr, 2000 July; 137 (1): 9-13.
10. Gressens P, Sola A. Environmental factors and disturbances of brain development. Semin Neonatol. 200;6(2):185-94.
11. Gressens P, Rogido M, Paindaveine B, Sola A. The Impact of Frequent Neonatal Intensive Care Practices on the Developing Brain. J Pediatr,140:646-653, 2002.
12. Rogido, M, Husson I, Bonnier C, Lallemand MC, Merienne C, Gregory GA, Sola A, Gressens P. Fructose-1, 6 biosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain. Brain Res Dev Brain Res, Feb;140:287-297, 2003.
13. Baserga MC, Gregory GA, Sola A. Cerebrovascular Response in Small Preterm Infants during Routine Nursery Gavage Feedings. Biol Neonate, 83:12-18, 2003.
14. Wen TC, Rogido M, Gressens P, Sola A. A reproducible experimental model of focal cerebral ischemia in the neonatal rat. Brain Research Protocols, 13:76-83, 2004.
15. Wen, TC, Rogido, M, Genetta, T, Sola, A. Permanent focal cerebral ischemia activates erythropoietin receptor I in the neonatal rat brain. Neurosci Lett, 355(3):165-168, 2004.
16. Valerie Boss, Augusto Sola, Tong-Chun Wen, Michael J. Decker. Mild Intermittent Hypoxis Does Not Induce Stress Responses in the Neonatal Rat Brain. Biology of the Neonate 2005;88:313-320
17. Sola A, Rogido M, Lee B, Genetta T, Wen TC. Erythropoietin after Focal Cerebral Ischemia Activates the Jaanus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res, Apr;57(4):481-7, 2005.
18. Sola A, Wen T-C, Hamrick S, Ferriero DM. Potential for Protection and Repair following Injury to the Developing Brain: A Role for Erythropoietin? Pediatr Res, May; 57(5), part 2:110R-117R, 2005.
19. Baserga M, Bertolotto C, Sola A. Different Doses of Dopamine have heterogeneous effects on Cerebral Hemodynamics and Dopamine Receptors in Young Rabbits as measured with Near-Infrared Spectroscopy. Biol Neonate, Jan 14;87(4):229-235, 2005.
20. Deulofeut R, Sola A. Injury to the Developing Brain in Term and Pre-Term Infants: Mechanisms of Injury and Potential for Prevention and Repair. Journal of The Arab Neonatology Forum, 2: 34-47; 2005.
21. Thomas Genetta, Ben H. Lee, Augusto Sola. Low doses of ethanol and hypoxia administered together act synergistically to promote the death of cortical neurons. Journal of Neuroscience Research, 2006;851(1): 131-138
22. Lee Ben H., Wen Tong-Chun, Rogido Marta, Sola Augusto. Glucocorticoid Receptor Expression in the Cortex of the Neonatal Rat Brain with and without Focal Cerebral Ischemia. Neonatology 2007;91:12-19
23. Baud Oliver, Sola Augusto Corticosteroids in perinatal medicine: How to imporve outcomes without affecting the developing brain?
24. Gender Differences in Long-Term Beneficial Effects of Erythropoietin Given After Neonatal Stroke in Postnatal Day-7 Rats. T.C. Wen, M. Rogido, H. Peng, T. Genetta, J. Moore and A. Sola Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA 30322, USA Neuroscience 139 (2006) 803-811

 

Oxygen and its consequences – Improving outcomes by changing the practice of oxygen administration and pulse oximetry monitoring:

 

1. Flynn JT, Sola A, Good WV, Phibbs RH. Screening for retinopathy of prematurity — a problem solved? Pediatrics. 1995 May;95(5):755-7
2. Chow LC, Wright KW, Sola A: Can changes in clinical practice decrease the incidence of severe retinopathy of Prematurity in Very Low Birth Weight Infants? Pediatrics, Feb: 111(2):339-45, 2003.
3. Sola A, Chow, L, Rogido M: Retinopathy of Prematurity and Oxygen Therapy: A Changing Relationship. An Pediatr (Barc), Jan;62(1):48-63, 2005.
4. Sola A, Chow L, Rogido M: Pulse oximetry in neonatal care in 2005. A comprehensive state of the art review. An Pediatr (Barc), Mar;62(3):266-281, 2005.
5. Augusto Sola, MD, Richard Deulofeut, MD, MPH: Oxygen and oxygenation in the delivery room. The Journal of Pediatrics, Volume 148, Issue 4, Pages 564-565 (April 2006
6. Deulofeut R, Critz A, Adams-Chapman I, Sola A: Avoiding hyperoxia in infants< 1250 g is associated with improved short-and long-term outcomes. Journal of Perinatology (2006) 26, 700-705 7. Sola A, Rogido MR, Deulofeut R.: Oxygen as a neonatal health hazard: Call for Détente in Clinical Practice. Acta Paediatr. 2007 Jun;96(6):798-800. 8. Treatment-by-gender effect when aiming to avoid hyperoxia in preterm infants in the NICU. Richard Deulofeut, Golde Dudell, Augusto Sola. Acta Paediatr. 2007 Jul;96(7):990-4. 9. Retinopathy of prematurity in the XXI century in a developing country: an emergency that should be resolved. Bouzas L, Bauer G, Novali L, Dilger A, Galina L, Falbo J, Díaz González L, Manzitti J, Sola A. An Pediatr (Barc). 2007 Jun;66(6):551-8. 10. Ophthalmologic and neonatal guidelines for ROP screening and treatment in Latin American Countries (October/2007) VISION 2020 The Right to Sight AMERICAS 11. Sola, A. Turn off the lights and the oxygen, when not needed: phototherapy and oxidative stress in the neonate. JPediatr (Rio J). 2007;83(4):293-296 12. Bouzas L, Bauer G, Novali L, Dilger A, Galina L, Falbo J, Díaz González L, Manzitti J, Sola A. Retinopathy of prematurity in the XXI century in a developing country: an emergency that should be resolved. An Pediatr (Barc). 2007 Jun;66(6):551-8 13. Sola A, Rogido M. Iron, oxidant injury, and practice choices in preterm infants. J Pediatr. 2008 Feb;152(2):295-6; 14. Castillo A, Sola A, Baquero H, Neira F, Alvis R, Deulofeut R, Critz A. Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: is 85% to 93% an acceptable range? Pediatrics. 2008 May;121(5):882-9 15. Sola A. Oxygen for the preterm newborn: one infant at a time. Pediatrics. 2008 Jun;121(6):1257 16. Sola A. Oxygen in neonatal anesthesia: friend or foe? Curr Opin Anaesthesiol. 2008 Jun;21(3):332-9. 17. Sola A, Saldeño YP, Favareto V. Clinical practices in neonatal oxygenation: where have we failed? What can we do? J Perinatol. 2008 May;28 Suppl 1:S28-34. 18. Various and Sola A. (“Grupo de Trabajo Colaborativo Multicéntrico para la Prevención de la Ceguera en la Infancia por Retinopatía del Prematuro”) Recommendations for Retinopathy of Prematurity screening in at-risk populations Arch Argent Pediatr. 2008 Feb;106(1):71-6

 

Sildenafil (Viagra) in Neonatal Pulmonary Hypertension and Severe hypoxemic respiratory failure in the newborn:

 

1. Hernando Baquero, Solis A, Freddy Neira, Maria E. Venegas and Augusto Sola: Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study. Pediatrics 2006:117;1077-1083
2. Baquero, H, Sola, A: Intratracheal Sildenafil in the Newborn With Pulmonary Hypertension. Pediatrics Volume 119, Number 1, January 2007 pages 215-216
3. Augusto Sola and Hernando Baquero: Oral Sildenafil in Neonatal Medicine: “Tested in adults also used in neonates”. An Pediatr (Barc). 2007;66(2):167-76
4. Lemus-Varela ML, Sola A , Gómez BC , Zamora AL , Ramos ML, Batista CM, Zúñiga GM: Oral sildenafil citrate lacks genotoxicity and cytotoxicity in a primate model: Callithrix jacchus. J Perinatol. 2006 Jul;26(7):423-7.
5. PEDIATRICS Volume 119, Number 1, January 2007. Intratracheal Sildenafil in the Newborn With Pulmonary Hypertension. Hernando Baquero, MD Augusto Sola, MD, Division of Neonatology, MANA and Morristown Memorial Hospital, Morristown, NJ 07962

 

Other recent publications of clinical interest:

 

1. Augusto Sola as senior author: Outcome of infants born at 24-26 weeks’ gestation: I. Survival and cost. Obstet Gynecol. 1997;90(5):803-8
2. Augusto Sola as senior author: Outcome of infants born at 24-26 weeks’ gestation: II. Neurodevelopmental outcome. Obstet Gynecol. 1997;90(5):809-14.
3. Harrison MR et al Correction of congenital diaphragmatic hernia in utero VIII: Response of the hypoplastic lung to tracheal occlusion. J Pediatr Surg. 1996;31(10):1339-48.
4. Harrison MR et al Correction of congenital diaphragmatic hernia in utero VII: a prospective trial. J Pediatr Surg. 1997;32(11):1637-42.
5. Metkus AP, Esserman L, Sola A, Harrison MR, Adzick NS. Cost per anomaly: what does a diaphragmatic hernia cost? J Pediatr Surg. 1995;30(2):226-30
6. Stringer MD, Sola A, Adzick NS, Harrison MR. Fetal diaphragmatic hernia without visceral herniation. J Pediatr Surg.. 1995;30(9):1264-6.
7. Sola A, Chow LC. The coming of (gestational) age for preterm infants. J Pediatr. 1999;135 (2 Pt 1):137-9
8. Renken IO, Sola A, Gooding CA. Direct coronal CT scanning of the neonatal chest. Pediatr Radiol. 1999;29(6):451-4.
9. Sola A, Farina D. Neonatal respiratory care and infant mortality in emerging countries. Pediatr Pulmonol. 1999 May;27(5):303-4.
10. First Trial on Synchronized Intermittent Mechanical Ventilation. Augusto Sola PI at UCSF. Randomized multicenter trial comparing synchronized and conventional intermittent mandatory ventilation in neonates. J Pediatr. 1996;128(4):453-63
11. Sola A, Rogido M. Pulmonary injury in the pre-term neonate. Neonatal Intsv Care, Oct 13(6):60-62, 2001.
12. Rogido M, Sola A. Ventilación mecánica en el recién nacido de muy bajo peso al nacer. UCIN, 2(1):40-51, 2002
13. Chow LC, Vanderhal A, Raber J, Sola A. Are tidal volume measurements in neonatal pressure-controlled ventilation accurate? Pediatr Pulmonol. 2002 Sep;34(3):196-202
14. Wong AF, Sola A. Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates. J Pediatr. 1992;121(6):980-3.
15. Baserga M, Puri A, Sola A. The Use of Topical Nitroglycerin Ointment to Treat Peripheral Tissue Ischemia Secondary to Arterial Line Complications in Neonates. J Perinatol. 2002;22:416-419
16. Deulofeut R, Sola A, Lee B, Buchter S, Rahman M, Rogido M. The impact of vaginal delivery in premature infants weighing less than 1,251 grams. Obstet Gynecol 2005;105(3):525-531
17. Delivery room cardiopulmonary resuscitation of the very preterm infant is associated with adverse short and long term outcomes. R. Deulofeut, A. Sola, B. Lee and M. Rogido Department of Pediatrics, Division of Neonatal-Perinatal Medicine, Emory University, Atlanta, Georgia And MidAtlantic Neonatology and Morristown Memorial Hospital, Morristown, New Jersey An Pediatr (Barc). 2007;66(1):31-7

 

Abstracts

 

In addition to the above publications Dr. Sola and his colleagues and trainees present research findings at various research societies like National Pediatric Academic Societies (Society for Pediatric Research, American Pediatric Society), International Societies and Regional Societies.

 

Research findings submitted to the APS/SPR Annual Meeting for 2008:

 

1. Inhibition of cleaved caspase-8 and caspase-3 by cardiotrophin-1 in the neonatal brain following focal cerebral ischemia and in cultured neurons exposed to sodium nitroprusside. Wen TC, Peng H, Rogido M, Sola A.
2. BAP31, an integral protein of the endoplasmic reticulum, expresses in ischemic cortex and in cleaved Caspase-8 and TUNEL-positive cells. Wen TC, Peng H, Rogido M, Sola A.
3. Endogenous cannabinoid system activation in neonatal focal cerebral ischemic injury in rat pups. Rogido MR, Martinez Orgado JA, Pazos R, Wen TC, Sola A, Romero J.
4. Is it possible to improve neonatal survival by uniform implementation of continuous quality care measures? The experience of Cuba. Dominguez F, Duenas E, Sola A.
5. Patency of the ductus: first clinical consensus of the Ibero-American Society of Neonatology. Golombek S, Sola A, and SIBEN PDA Consensus Group.
6. Late onset neonatal pulmonary hypertension: Role of persistently prolonged patent ductus? Saldeño YP, Favareto V, Rogido M, Sola A.
7. Saturation limits and alarm settings in a NICU: What is the sound of one hand clapping? Favareto V, Saldeño YP, Rogido M, Sola A.
8. Prolonged persistent patent ductus arteriosus: Potential perdurable anomalies in premature infants. Mirpuri J, Sola A, Favareto V, Saldeño YP, Goldsmit G, Fariña D, Lee BH, Schenkman A. Rogido M
9. Clinical Practice Assessing Problems: Prospective Evaluation of Continuous Positive Airway Pressure in The Early XXI Century. Saldeño YP, Favareto V, Rogido M, Sola A.
10. Lower SpO2 targets and incidence of patent ductus arteriosus. Castillo A, Deulofeut R, Sola A.
11. High PaO2 is directly proportional to SpO2 levels 94%-100% in newborns receiving oxygen in the neonatal intensive care unit. Castillo A, Baquero H, Neira F, Alvis R, Critz A, Deulofeut R, Sola A.
12. A Brief History of the Use of Oxygen in Neonatology. Golombek S, Sola A
13. What Is The Risk Of Low Pao2 In Newborns Receiving Supplemental Oxygen In The Neonatal Intensive Care Unit When Spo2 Is 85%To93%? Castillo A, Baquero H, Neira F, Alvis R, Critz A, Deulofeut R, Sola A
14. Neurological Follow-Up (48 Months) Of Patients Treated With Oral Sildenafil For Severe Neonatal Pulmonary Hypertension In Nicu Where iNO Is Not Available Baquero H, Venegas ME, Lorena V, Neira F, Sola A.
15. Different Approach To The Use Of Intravenous Sodium Bicarbonate In Asphyxia Among European Neonatologists. Saenz P, de Jhong B, Aguar M, Brugada M, Sola A, Vento M
16. An International Survey On Intravenous Sodium Bicarbonate Use In Neonatology. Saenz P, de Jhong B, Aguar M, Brugada M, Sola A, Vento M

 

Listed below are some of the many abstracts presented at National Pediatric Academic Societies (Society for Pediatric Research, American Pediatric Society), International Societies and Regional Societies for 2006 and 2007:

 

1. A Sola, A Schenkman, L Skolnick, M Rogido: Prevention of retinopathy of prematurity. European Academy of Paediatrics and ESPR, 2006 Oct, page 64
2. A Castillo, H Baquero, F Neira, R Deulofeut, A Sola: Levels of (Spo2) between 85% and 93% are associated with normoxemia in newborns (NB) receiving oxygen therapy (FiO2>21%) in the neonatal intensive care unit (NICU). EAP and ESPR, 2006, Oct, page 65
3. Augusto Sola, Ben Lee: Uniform Application of Neonatal Guidelines Without Adequate Evidence: the Illusion of Knowledge? PAS and Eastern SPR Annual Meeting, 2007
4. A. Castillo, R. Deulofeut and A. Sola: Clinical Practice andSpO2 Technology in the Prevention of ROP in ELBW infants. PAS and Eastern SPR Annual Meeting, 2007
5. A. Sola: Education in Neonatal oxygenation Has Been Insufficient: A Need for Darning. PAS and Eastern SPR Annual Meeting, 2007
6. Hypothermia increases erythropoietin receptor expression in neurons through an adenosine and ATP signaling pathway. Moore J, Peng H, Wen TC, Rogido M, Sola A.
7. Avoiding hyperoxemia during neonatal resuscitation: Time to response of different SpO2 monitors. Baquero H, Sola A
8. Clinical practice and SpO2 technology in the prevention of ROP in ELBW infants. Castillo A, Sola A
9. TOI (Tissue Oxygenation Index) and arterial saturation (SaO2) in extremely low birth weight infants: Are they associated? Bravo C, Cabanas F, Sola A, Madero R, Gaya F, Quero J, Pellicer A.